Group 5/15 Element Organic Compounds TRIZ Cases

Removing negative regulatory mechanisms from adult pancreatic beta cells overcomes senescence barriers, restoring proliferation capacity for diabetes therapy.

Ester prodrugs improve cellular permeability of tenofovir, maintaining antiviral effectiveness against mutant HIV strains resistant to existing therapies.

DMSO and monoethanolamine solubilize water-insoluble inhibitors, reducing nitrogen loss through runoff.

Phosphorus-silicon coatings prevent galvanic corrosion between dissimilar metals by forming protective barriers that maintain bond strength.

A phosphorous flame retardant uses a styrene functional group and phosphorus backbone to achieve low dielectric constant.

A nitrile ligated transition metal-phosphinobenzene-sulfonate complex enables insertion copolymerization of functional olefins with ethylene.

An OLED mixed electron transport layer with concentration gradients prevents hole leakage, reducing driving voltage while maintaining charge balance.

Borane activation enables mild Arbuzov synthesis of hydroxy-bisphosphonic acid derivatives, preserving sensitive functional groups without protection steps.

A supported double metal cyanide catalyst system enhances epoxide polymerization rates and controls molecular weight distribution.

A phosphorus-oxygen compound enhances electron mobility and thermal stability in organic electroluminescent devices.

Silylated phosphines react with acylhalides using Lewis acid catalysts to produce mono- and bisacylphosphines.

Liquid bisacylphosphine oxide photoinitiator mixture via transesterification.

A group 10 metal complex catalyst enables efficient copolymerization of ethylene with polar monomers.

A high-functionality isocyanate compound accelerates coating drying while maintaining reactivity.

Acrylonitrile derivatives block BCRP-mediated efflux to overcome chemotherapy resistance and enhance oral bioavailability of anticancer agents.

Reacting phosphonic acids with metals yields thermally stable flame retardants for high-temperature polymer compositions.

Phosphate salt additive delivers high block resistance in architectural paints while meeting environmental compliance standards.

Thienopyrimidine compounds bind menin to disrupt MLL fusion interactions, treating leukemias.

Spiro compounds with azafluorene rings emit delayed fluorescence, utilizing triplet excitons to overcome low quantum yield limits in OLEDs.

Bicellar mixture deposition forms solid-supported phospholipid bilayers at low lipid concentrations, avoiding surfactant-induced destabilization.

Spiro structure compound improves electron injection and transport, reducing driving voltage while extending device lifetime.

A stabilized Tetrofosmin bis-phosphonium tetrafluoroborate salt enables high radiochemical yield with pertechnetate under normal atmospheric conditions.

Specific acyclonucleoside derivatives modify molecular structure to suppress DNA viruses while minimizing systemic toxicity and resistance development.

Seeding PMIDA reaction solutions controls crystal growth to resolve filtration inefficiency and impurity inclusion.

Phosphorus additives form stable solid electrolyte interphase layers on silicon anodes.

A cyclotriphosphazene derivative enhances electrolyte flame retardancy while maintaining battery stability and capacity retention.

Fluorine substitution and aromatic ring modification enhance STAT3 inhibitory potency while resolving pharmacokinetic stability liabilities.

Pyrimidine-based electron transport material reduces driving voltage and extends operational lifespan by optimizing energy level alignment.

Acridine derivatives replace heavy metal phosphors with pure organic structures to achieve high internal quantum efficiency and efficient luminescence.

HPP derivatives modify polyimide side chains to inhibit charge-transfer complexes, reducing color while maintaining thermal stability.

Artemisinin-dipeptidyl vinyl compounds inhibit falcipain-2 and heme polymerization via etherification coupling.

Aminopyrimidine compounds inhibit EGFR kinase activity to overcome C797S mutation resistance.

Ether compounds inhibit complement Factor D, reducing excessive activation and inflammatory responses in medical disorders.

Reacting methyl halogenated phosphonate monoester with 3,3-dialkoxypropyl magnesium or zinc halide yields the target phosphonate compound.

Lipophilic galantamine prodrugs overcome low hydrophobicity to achieve higher brain accumulation and reduced peripheral side effects.

Modified tin complexes with alkynyl phosphonic acid ligands exhibit strong antitumor activity against cancer cells.

Fluoroalkylphosphines mediate selective pyridine fluoroalkylation through phosphonium salts, bypassing radical limitations.

Controlling phosphate ion content within 5 to 8,000 ppm prevents molded product coloring while maintaining crystallization temperature.

Crystallizing thiophosphoric acid derivatives from ethyl acetate avoids thermal decomposition during isolation.

Planar condensed cyclic compound with two heteroatoms increases electron mobility in organic light-emitting devices.

High-purity organic phosphorus compound provides effective flame protection without corrosive gas generation or loss of physical properties.

Thiol-substituted acylphosphine oxide photoinitiators minimize odor and migration by altering degradation pathways, enabling low viscosity inkjet inks.

A condensed cyclic compound with a 5-membered heteroaromatic ring increases singlet energy levels and oscillator strength.

Segmenting the synthesis into a phosphite ester intermediate stage reduces acidity and water content, enabling direct use in polyurethane foam compositions.

Phosphorous acid compound prevents molecular cleavage in polyolefins during high-temperature processing.

Single-molecule bifunctional extractants replace synergic mixtures to selectively recover uranium while reducing iron contamination.

Introducing aromatic quaternary phosphonium compounds into the slurry resolves the trade-off between high silicon oxide removal rates and scratch defects.

Switching zoledronic acid to disodium salt overcomes low oral bioavailability, sustaining plasma levels and extending pain relief duration.